Literature DB >> 8291444

Establishment and characterization of a human lung adenocarcinoma cell line (LC-2/ad) producing alpha 1-antitrypsin in vitro.

H Kataoka1, H Itoh, K Seguchi, M Koono.   

Abstract

A new human cell line, LC-2/ad was established from pleural effusion of pulmonary adenocarcinoma of a 51 year old Japanese female. The LC-2/ad cells exhibit an epithelial appearance and a tendency to form small domes as observed with phase-contrast microscopy. The modal chromosome number was 53-56. Plating efficiency and doubling time were 6.8% and 58 h, respectively (32th passage). Immunocytochemically, the cells were strongly positive for CEA and cytokeratins including cytokeratin no. 18 which is present in simple epithelia. Ultrastructurally, the cultured cells were characterized by well-formed junctional complexes and microvilli. Subcutaneous injection of 5 x 10(6) cells into a nude mouse resulted in tumor formation classified histologically as a moderately differentiated adenocarcinoma. This cell line produced at least two functionally active trypsin inhibitors together with several proteinases in vitro. The main inhibitor was purified partially from the serum-free conditioned medium and confirmed immunologically as human alpha 1-antitrypsin (AAT). Immunohistochemically, the xenografted tumor was also positive for AAT. The cell line LC-2/ad is useful for the study of tumor-derived serine proteinase inhibitors, in particular AAT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8291444     DOI: 10.1111/j.1440-1827.1993.tb03232.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  3 in total

1.  Identification and characterization of different subpopulations in a human lung adenocarcinoma cell line (A549).

Authors:  M V Croce; A G Colussi; M R Price; A Segal-Eiras
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

2.  Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.

Authors:  Y Oji; H Ogawa; H Tamaki; Y Oka; A Tsuboi; E H Kim; T Soma; T Tatekawa; M Kawakami; M Asada; T Kishimoto; H Sugiyama
Journal:  Jpn J Cancer Res       Date:  1999-02

3.  Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.

Authors:  Makito Suzuki; Hideki Makinoshima; Shingo Matsumoto; Ayako Suzuki; Sachiyo Mimaki; Koutatsu Matsushima; Kiyotaka Yoh; Koichi Goto; Yutaka Suzuki; Genichiro Ishii; Atsushi Ochiai; Koji Tsuta; Tatsuhiro Shibata; Takashi Kohno; Hiroyasu Esumi; Katsuya Tsuchihara
Journal:  Cancer Sci       Date:  2013-05-12       Impact factor: 6.716

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.